95 results on '"Ciosek, J."'
Search Results
2. Galanin influences on vasopressin and oxytocin release: In vitro studies
- Author
-
Izdebska, K. and Ciosek, J.
- Published
- 2010
- Full Text
- View/download PDF
3. Ion mass interferences and matrix effects on SIMS depth profiling of thin Ti/Si multilayer films induced by hydrogen, carbon and oxygen contaminations
- Author
-
Cwil, M., Konarski, P., and Ciosek, J.
- Published
- 2007
- Full Text
- View/download PDF
4. Influence of temperature–pressure treatment on heavily hydrogenated silicon surface
- Author
-
Ciosek, J. and Ratajczak, J.
- Published
- 2006
- Full Text
- View/download PDF
5. Barrier properties of Ta–Si–N films in Ag-and Au-containing metallization
- Author
-
Kuchuk, A.V., Ciosek, J., Piotrowska, A., Kaminska, E., Wawro, A., Lytvyn, O.S., Nowicki, L., and Ratajczak, R.
- Published
- 2004
- Full Text
- View/download PDF
6. Modification of zirconium oxide film microstructure during post-deposition annealing
- Author
-
Ciosek, J., Paszkowicz, W., Pankowski, P., Firak, J., Stanislawek, U., and Patron, Z.
- Published
- 2003
- Full Text
- View/download PDF
7. Cardiopoietic cell therapy for advanced ischemic heart failure : results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
- Author
-
Bartunek, Jozef, Terzic, Andre, Davison, Beth A, Filippatos, Gerasimos S, Radovanovic, Slavica, Beleslin, Branko, Merkely, Bela, Musialek, Piotr, Wojakowski, Wojciech, Andreka, Peter, Horvath, Ivan G, Katz, Amos, Dolatabadi, Dariouch, El Nakadi, Badih, Arandjelovic, Aleksandra, Edes, Istvan, Seferovic, Petar M, Obradovic, Slobodan, Vanderheyden, Marc, Jagic, Nikola, Petrov, Ivo, Atar, Shaul, Halabi, Majdi, Gelev, Valeri L, Shochat, Michael K, Kasprzak, Jaroslaw D, Sanz Ruiz, Ricardo, Heyndrickx, Guy R, Nyolczas, Noémi, Legrand, Victor, Guédès, Antoine, Heyse, Alex, Moccetti, Tiziano, Fernandez Aviles, Francisco, Jimenez Quevedo, Pilar, Bayes Genis, Antoni, Hernandez Garcia, Jose Maria, Ribichini, Flavio, Gruchala, Marcin, Waldman, Scott A, Teerlink, John R, Gersh, Bernard J, Povsic, Thomas J, Henry, Timothy D, Metra, Marco, Hajjar, Roger J, Tendera, Michal, Behfar, Atta, Alexandre, Bertrand, Seron, Aymeric, Stough, Wendy Gattis, Sherman, Warren, Cotter, Gad, Wijns, W. i. l. l. i. a. m. Collaborators Clinical investigators, Dens, sites Belgium: Ziekenhuis Oost Limburg: J., Dupont, M., Mullens, W., Janssens, M., Dolatabadi, Hoˆpital Civil de Charleroi: D., De Bruyne, Y., Lalmand, J., Dubois, P., El Nakadi, B., Aminian, A., De Vuyst, E., Gurnet, P., Gujic, M., Blankoff, I., Guedes, CHU Mont Godinne UCL: A., Gabriel, L., Seldrum, S., Doyen, C., Andre´, M., Heyse, AZ Glorieux: A., Van Durme, F., Verschuere, J., Legrand, Domaine Universitaire du Sart Tilman: V., Gach, O., D’Orio, V., Davin, L., Lancellotti, P., Baudoux, E., Ancion, A., Dulgheru, R., Vanderheyden, OLV Ziekenhuis Aalst – Cardiologie: M., Bartunek, J., Wijns, W., Verstreken, S., Penicka, . M., Gelev, P. Meeus Bulgaria: Tokuda Hospital Sofia: V., Zheleva Kichukova, I., Parapunova, R., Melamed, R., Sardovski, S., Radev, O., Yordanov, A., Radinov, A., Nenov, D., Amine, I., Petrov, City Hospital Clinic Cardiology Center: I., Kichukov, K., Nikitasov, L., Stankov, Z., Stoyanov, H., Tasheva Dimitrova, I., Angelova, M., Dimitrov, E., Minchev, M., Garvanski, I., Botev, C., Polomski, P., Alexandrovska University Hospital, Vassilev, Sofia: D., Karamfiloff, K., Tarnovska Kadreva, R., Vladimirova, L., Dimitrov, G., Hadzhiev, E., Tzvetkova, G., Andreka, . M. Atanasova Hungary: Gottsegen Gyo¨ rgy Orszagos Kardiologiai Inte´zet: P., Fontos, G., Fabian, J., Csepregi, A., Uzonyi, G., Gelei, A., Edes, Debreceni Egyetem Orvos e´s Ege´szse´gtudomanyi Centrum Altalanos Orvostudomanyi Kar Kardiologia Inte´zet: I., Balogh, L., Vajda, G., Darago, A., Gergely, S., Fulop, T., Jenei, C., Horvath, Pe´csi Tudomanyegyetem Klinikai Ko¨zpont Szıvgyogyaszati Klinika: I., Magyari, B., Nagy, A., Cziraki, A., Faludi, R., Kittka, B., Alizadeh, H., Merkely, Semmelweis Egyetem Varosmajori Szıv e´s Ergyogyaszati Klinika: B., Geller, L., Farkas, P., Szombath, G., Foldes, G., Skopal, J., Kovacs, A., Kosztin, A., Gara, E., Sydo, N., Nyolczas, MH Ege´szse´gu¨gyi Ko¨zpont Kardiologiai Osztaly: N., Kerecsen, G., Korda, A., Kiss, . M., Borsanyi, T., Polgar, B., Muk, B., Sharif, Z. Bari Ireland: HRB Clinical Research Facility: F., Atar, Y. M. Smyth Israel:Western Galilee Hospital: S., Shturman, A., Akria, L., Kilimnik, M., Brezins, M., Halabi, Ziv Medical Center: M., Dally, N., Goldberg, A., Aehab, K., Rosenfeld, I., Levinas, T., Saleem, D., Katz, Barzilai Medical Center: A., Plaev, T., Drogenikov, T., Nemetz, A., Barshay, Y., Jafari, J., Orlov, I., Nazareth Hospital EMMS: M. Omory, N. Kogan Nielsen, Shochat, Hillel Yaffe Medical Center: M., Shotan, A., Frimerman, A., Meisel, S., Asif, A., Sofer, O., Blondheim, D. S., Vazan, A., Metra, L. Arobov Italy: A. O. Spedali Civili di Brescia: M., Bonadei, I., Inama, L., Chiari, E., Lombardi, C., Magatelli, M., Russo, D., Lazzarini, V., Carubelli, V., Vassanelli, AOUI Verona – Borgo Trento Hospital: C., Ribichini, Flavio Luciano, Bergamini, C., Krampera, Mauro, Cicoria, M. A., Zanolla, L., Dalla Mura, D., Gambaro, A., Rossi, A., Pesarini Poland: Jagiellonian University Department of Cardiac, G., Musialek, Vascular Diseases at John Paul II Hospital in Krakow: P., Mazurek, A., Drabik, L., Ka˛dzielski, A., Walter, Z., Dzieciuch Rojek, M., Rubis, P., Plazak, . W., Tekieli, L., Podolec, J., Orczyk, W., Sutor, U., Zmudka, K., Olszowska, M., Podolec, P., Gruchala, Uniwersyteckie Centrum Kliniczne: M., Ciecwierz, D., Mielczarek, M., Burakowski, S., Chmielecki, M., Zielinska, M., Frankiewicz, A., Wdowczyk, J., Stopczynska, I., Bellwon, J., Mosakowska, K., Nadolna, R., Wroblewska, J., Rozmyslowska, M., Rynkiewicz, M., Marciniak, I., Raczak, G., Tarnawska, M., Taszner, M., Kasprzak, Bieganski Hospital: J., Plewka, M., Fiutowska, D., Rechcinski, T., Lipiec, P., Sobczak, M., Weijner Mik, P., Wraga, M., Krecki, R., Markiewicz, M., Haval Qawoq, D., Wojakowski, Gornosla˛skie Centrum Medyczne Sla˛skie j. Akademii Medycznej: W., Ciosek, J., Dworowy, S., Gaszewska Zurek, E., Ochala, A., Cybulski, W., Jadczyk, T., Wanha, W., Parma, Z., Kozlowski, M., Dzierzak, M., Markiewicz Serbia: Clinical Hospital Center Zvezdara, M., Arandjelovic, Cardiology Clinic: A., Sekularac, N., Boljevic, D., Bogdanovic, A., Zivkovic, S., Cvetinovic, N., Loncar, G., Clinical Centre of Serbia, Beleslin, Cardiology Clinic: B., Nedeljkovic, M., Trifunovic, D., Giga, V., Banovic, M., Nedeljkovic, I., Stepanovic, J., Vukcevic, V., Djordjevic Dikic, A., Dobric, M., Obrenovic Kircanski, B., Seferovic, Cardiology Clinic: P., Orlic, D., Tesic, M., Petrovic, O., Milinkovic, I., Simeunovic, D., Jagic, Clinical Center of Kragujevac: N., Tasic, M., Nikolic, D., Miloradovic, V., Djurdjevic, P., Sreckovic, M., Zornic, N., Clinical Hospital Center Bezanijska Kosa, Radovanovic, Cardiology Department: S., Saric, J., Hinic, S., Djokovic, A., Ðordevic, S., Bisenic, V., Markovic, O., Stamenkovic, S., Malenkovic, V., Tresnjak, J., Misic, G., Cotra, D., Tomovic, L., Vuckovic, V., Clinic of Emergency Internal Medicine, Obradovic, Military Medical Academy: S., Jovic, Z., Vukotic, S., Markovic, D., Djenic, N., Ristic Andjelkov, A., Bayes Genis, D. Ljubinka Spain: Hospital Universitario Germans Trias I. Pujol: A., Rodriguez Leor, O., Labata, C., Vallejo, N., Ferrer, E., Batlle, M., Fernandez Aviles, Hospital General Universitario Gregorio Mara~non: F., Sanz Ruiz, R., Casado, A., Loughlin, G., Zatarain, E., Anguita, J., Ferna ndez Santos, M. E., Pascual, C., Bermejo, J., Hernandez Garcia, Hospital Clinico Universitario Virgen de la Victoria: J. M., Jimenez Navarro, M., Dominguez, A., Carrasco, F., Mu~noz, A., Garcia Pinilla, J. M., Ruiz, J., Queipo de Llano, M. P., Hernandez, A., Fernandez, A., Jimenez Quevedo, Hospital Clinico San Carlos: P., Guerra, R., Biagioni, C., Gonzalez, R. A., Gomez deDiego, J. J., Mansson Broberg, L. Perez de Isla Sweden: Karolinska University Hospital: A., Sylve´n, C., Leblanc, K., Winter, R., Blomberg, P., Gunyeli, E., Ruck, A., Silva, C., Fo¨rstedt Switzerland: CardioCentro Ticino, J., Moccetti, Switzerland: T., Rossi, M., Pasotti, E., Petrova, I., Crljenica, C., Monti, C., Murzilli, R., Su¨rder, D., Moccetti, M., Turchetto, L., Locicero, V., Chiumiento, L., Maspoli, S., Mombelli, M., Anesini, A., Biggiogero, M., Ponti, G., Camporini, C., Polledri, S., Hill, G. Dolci United Kingdom: Kings College Hospital: J., Plymen, C., Amin Youssef, G., Mcdonagh, T., Drasar, E., Mijovic, A., Jouhra, F., Mcloman, D., Dworakowski, R., Webb, I., Byrne, J., and Potter, V.
- Subjects
0301 basic medicine ,Male ,Cardiopoiesis ,Cardiovascular disease ,Disease severity ,Marker ,Precision medicine ,Regenerative medicine ,Stem cell ,Target population ,Adult ,Aged ,Double-Blind Method ,Female ,Heart Failure ,Humans ,Mesenchymal Stem Cell Transplantation ,Middle Aged ,Myocardial Ischemia ,Prospective Studies ,Treatment Outcome ,Young Adult ,Cardiology and Cardiovascular Medicine ,Cell- and Tissue-Based Therapy ,mesenchymal stem-cells ,030204 cardiovascular system & hematology ,Cardiorespiratory Medicine and Haematology ,outcomes ,Fast-Track Clinical Research ,Sudden cardiac death ,0302 clinical medicine ,Ischemia ,cardiovascular disease ,Clinical endpoint ,target population ,CHART Program ,Ejection fraction ,bone-marrow ,Heart Failure/Cardiomyopathy ,3. Good health ,Cohort ,Cardiology ,Fast Track ,disease severity ,delivery ,medicine.medical_specialty ,precision medicine ,Clinical Sciences ,regenerative medicine ,03 medical and health sciences ,cardiopoiesis ,Internal medicine ,medicine ,Adverse effect ,marker ,disease ,business.industry ,medicine.disease ,mortality ,Confidence interval ,Clinical trial ,stem cell ,Editor's Choice ,030104 developmental biology ,predictors ,Cardiovascular System & Hematology ,Heart failure ,business - Abstract
Altres ajuts: This work was supported by Celyad, SA (Mont-Saint-Guibert, Belgium). Celyad has received research grants from the Walloon Region (Belgium, DG06 funding). Cardiopoietic cells, produced through cardiogenic conditioning of patients' mesenchymal stem cells, have shown preliminary efficacy. The Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial aimed to validate cardiopoiesis-based biotherapy in a larger heart failure cohort. This multinational, randomized, double-blind, sham-controlled study was conducted in 39 hospitals. Patients with symptomatic ischaemic heart failure on guideline-directed therapy (n = 484) were screened; n = 348 underwent bone marrow harvest and mesenchymal stem cell expansion. Those achieving > 24 million mesenchymal stem cells (n = 315) were randomized to cardiopoietic cells delivered endomyocardially with a retention-enhanced catheter (n = 157) or sham procedure (n = 158). Procedures were performed as randomized in 271 patients (n = 120 cardiopoietic cells, n = 151 sham). The primary efficacy endpoint was a Finkelstein–Schoenfeld hierarchical composite (all-cause mortality, worsening heart failure, Minnesota Living with Heart Failure Questionnaire score, 6-min walk distance, left ventricular end-systolic volume, and ejection fraction) at 39 weeks. The primary outcome was neutral (Mann–Whitney estimator 0.54, 95% confidence interval [CI] 0.47–0.61 [value > 0.5 favours cell treatment], P = 0.27). Exploratory analyses suggested a benefit of cell treatment on the primary composite in patients with baseline left ventricular end-diastolic volume 200–370 mL (60% of patients) (Mann–Whitney estimator 0.61, 95% CI 0.52–0.70, P = 0.015). No difference was observed in serious adverse events. One (0.9%) cardiopoietic cell patient and 9 (5.4%) sham patients experienced aborted or sudden cardiac death. The primary endpoint was neutral, with safety demonstrated across the cohort. Further evaluation of cardiopoietic cell therapy in patients with elevated end-diastolic volume is warranted.
- Published
- 2017
8. Study of the Effectiveness of Anodic Films as Surface Passivation for InAsSb Mid-Wave Infrared HOT Detectors
- Author
-
Michalczewski, K., primary, Gomółka, E., additional, Ciosek, J., additional, Kubiszyn, Ł., additional, Benyahia, D., additional, Lipski, K., additional, Martyniuk, P., additional, Piotrowski, J., additional, and Rogalski, A., additional
- Published
- 2018
- Full Text
- View/download PDF
9. Long term stability study of InAsSb mid-wave infrared HOT detectors passivated through two step passivation technique.
- Author
-
Michalczewski, K., Ivaldi, F., Kubiszyn, Ł., Benyahia, D., Ciosek, J., Boguski, J., Kębłowski, A., Martyniuk, P., Piotrowski, J., and Rogalski, A.
- Published
- 2018
- Full Text
- View/download PDF
10. DISRUPTION OF HISTAMINE/H3 RECEPTOR SIGNAL REDUCES COLLAGEN DEPOSITION IN CULTURES SCAR MYOFIBROBLASTS.
- Author
-
PIERA, L., OLCZAK, S., KUN, T., GALDYSZYNSKA, M., CIOSEK, J., SZYMANSKI, J., and DROBNIK, J.
- Subjects
MYOFIBROBLASTS ,ANTIHISTAMINES ,HISTAMINE receptors ,COLLAGEN ,MAST cells - Abstract
A suitable inflammatory signal influences extracellular matrix accumulation and determines the quality of the myocardial infarction scar. The aim of the present study was to determine the influence of mast cell sonicates or histamine on collagen accumulation in heart myofibroblast culture and on the deposition of collagen in the myocardial infarction scar. The histamine receptor involved in the process was investigated. Myocardial infarction was induced by ligation of the left coronary artery. Myofibroblasts were isolated from the scar of myocardial infarction. The effects of mast cell sonicates, histamine and its receptor antagonists, i.e. ketotifen (H
1 -receptor inhibitor), ranitidine (H2 -receptor inhibitor), ciproxifan (H3 -receptor inhibitor), JNJ7777120 (H4 -receptor inhibitor), imetit (H3 receptor agonist), were investigated. The mast cell sonicates or histamine (10-10 - 10-5 M) augmented collagen content in myofibroblast cultures; however, histamine-induced elevation was reduced by ciproxifan (10-5 M, 10-6 M). Imetit (10-9 - 10-5 M) elevated collagen content in the culture. H3 receptor expression on myofibroblasts was confirmed. Our findings indicate that histamine increases the deposition of collagen in cultures of myofibroblasts isolated from the myocardial infarction scar. This effect is dependent on H3 receptor activation. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
11. Long term stability study of InAsSb mid-wave infrared HOT detectors passivated through two step passivation technique
- Author
-
Struk, Przemyslaw, Pustelny, Tadeusz, Michalczewski, K., Ivaldi, F., Kubiszyn, Ł., Benyahia, D., Ciosek, J., Boguski, J., Kębłowski, A., Martyniuk, P., Piotrowski, J., and Rogalski, A.
- Published
- 2018
- Full Text
- View/download PDF
12. 424 Mobilization of CXCR4+/CD34+ stem cells early in acute myocardial infarction is correlated with left ventricular ejection fraction and NT-proBNP levels after 1 year of follow-up (MRI study)
- Author
-
WOJAKOWSKI, W, primary, WYDERKA, R, additional, MASLANKIEWICZ, K, additional, CIOSEK, J, additional, OCHALA, A, additional, ZEBZDA, A, additional, BUSZMAN, P, additional, RATAJCZAK, M, additional, and TENDERA, M, additional
- Published
- 2006
- Full Text
- View/download PDF
13. Zr-silicate co-evaporated thin films
- Author
-
Ciosek, J., primary, Paszkowicz, W., additional, Kudla, A., additional, Pankowski, P., additional, and Stanislawek, U., additional
- Published
- 2005
- Full Text
- View/download PDF
14. Remarks on the Slits Experiments.
- Author
-
Ciosek, J.
- Published
- 2006
- Full Text
- View/download PDF
15. Zr-silicate co-evaporated thin films.
- Author
-
Ciosek, J., Paszkowicz, W., Kudla, A., Pankowski, P., and Stanislawek, U.
- Published
- 2005
- Full Text
- View/download PDF
16. Electrically driven polarization-insensitive liquid crystal narrow-bandpass intensity modulator
- Author
-
Nowinowski-Kruszelnicki, E., primary, Ciosek, J., additional, Walczak, A., additional, and Kłosowicz, S.J., additional
- Published
- 1998
- Full Text
- View/download PDF
17. The design and manufacture of all-dielectric non-polarizing beam splitters
- Author
-
Ciosek, J., primary, Dobrowolski, J.A., additional, Clarke, G., additional, and Laframboise, G., additional
- Published
- 1997
- Full Text
- View/download PDF
18. Thyroliberin and the daily rhythm of vasopressin and oxytocin release from the hypothalamo-neurohypophysial system
- Author
-
Ciosek, J. and Stempniak, B.
- Published
- 1998
- Full Text
- View/download PDF
19. Narrow-band interference filter with polarizing feature
- Author
-
Ciosek, J.
- Published
- 1997
- Full Text
- View/download PDF
20. Transmittance; when the probable becomes the real.
- Author
-
Ciosek, J.
- Published
- 2002
- Full Text
- View/download PDF
21. Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction.
- Author
-
Wojakowski W, Tendera M, Kucia M, Zuba-Surma E, Paczkowska E, Ciosek J, Halasa M, Król M, Kazmierski M, Buszman P, Ochala A, Ratajczak J, Machalinski B, Ratajczak MZ, Wojakowski, Wojciech, Tendera, Michał, Kucia, Magda, Zuba-Surma, Ewa, Paczkowska, Edyta, and Ciosek, Joanna
- Abstract
Objectives: This study sought to assess of the mobilization of nonhematopoietic very small embryonic-like stem cells (VSELs) in acute myocardial infarction (MI).Background: Acute MI induces mobilization of bone marrow stem cells. Recently, a rare population of VSELs, expressing markers of embryonic pluripotent stem cells (PSCs), was identified in adult murine bone marrow and human umbilical cord blood.Methods: Thirty-one patients with acute MI and 30 healthy subjects were enrolled. Blood was sampled on admission, after 24 h, and 5 days later. Erythrocytes were lysed and lin(-)CD45(-) VSELs were isolated using a live cell sorting system (FACSAria, Beckton Dickinson, San Jose, California).Results: In healthy subjects the median number of circulating VSELs was very low (median 0.8 [range 0 to 1.3]) cells/microl. In acute MI, VSELs were mobilized early (median 2.7 [range 0.2 to 3.9] cells/microl; p < 0.001) and remained elevated after 24 h and 5 days (median 4.7 [range 0.2 to 6.4] cells/microl; p < 0.003, and median 2.6 [range 0.3 to 3.6] cells/microl; p < 0.03, respectively). The mobilization of VSEL was significantly reduced in patients older than 50 years and with diabetes in comparison with younger and nondiabetic patients. Circulating VSELs were small (7 to 8 microm) and enriched in the messenger ribonucleic acid of PSC markers (Oct-4, Nanog), cardiac lineage (GATA-4, Nkx2.5/Csx, MEF2C), and endothelial (VE-cadherin) markers. The presence of PSC markers (Oct-4, SSEA-4) and the chemokine receptor CXCR4 in circulating VSELs was confirmed at the protein level by immunofluorescent staining and ImageStream system (Amnis Corporation, Seattle, Washington) analysis.Conclusions: Acute MI induced mobilization of VSELs expressing pluripotent markers, early cardiac and endothelial markers, and chemokine receptor CXCR4. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
22. The role of external iliac artery diameter indexed to BSA score in predicting vascular access complications after transfemoral transcatheter aortic valve implantation.
- Author
-
Gruz-Kwapisz M, Gasior T, Hajder A, Wanha W, Ciosek J, Ochala A, Parma R, Gocol R, Wojakowski W, and Hudziak D
- Abstract
Introduction: Aortic stenosis is the most common primary valve disease and requires invasive treatment. Transcatheter aortic valve implantation (TAVI) from a transfemoral access is a routine intervention worldwide., Aim: To investigate the correlation between external iliac artery diameter (EIAD) indexed to body surface area (BSA) (EIAD-BSA) and access site complications in patients undergoing TAVI via transfemoral access (TF) (TF-TAVI)., Material and Methods: Patients underwent TF-TAVI in 2017-2019 at the Upper-Silesian Medical Center in Katowice. Based on the preoperative multi-slice computed tomography (MSCT), pre-specified measurements of the ilio-femoral vessels were performed. The results were indexed to BSA and body mass index (BMI). Complications after TAVI were defined by Valve Academic Research Consortium 3 (VARC-3). The primary outcome regarding the adverse events after TAVI was the composite of access site complications requiring surgical intervention or blood transfusion., Results: The registry included 193 unselected patients with severe symptomatic aortic stenosis. Vascular and access-related complications including bleeding occurred in 17.1% of patients. Major TAVI access site complications (VARC-3) were reported in 5.7% of patients, while minor complications (VARC-3) occurred in 2.6%. EIAD-BSA demonstrated a positive correlation with the access site complications primary endpoint. Patients with greater EIAD-BSA had a numerically higher number of access site adverse events requiring surgical intervention or blood transfusion: n = 12 (5%) vs. n = 4 (4%), p = 0.011., Conclusions: External iliac artery diameter indexed to BSA could be an underestimated indicator of unfavorable outcomes after TF-TAVI, predicting periprocedural access site complications., Competing Interests: Tomasz Gasior is an employee of Boehringer Ingelheim. Other authors declare no conflict of interest., (Copyright: © 2024 Termedia Sp. z o. o.)
- Published
- 2024
- Full Text
- View/download PDF
23. Juvenile idiopathic epilepsy in Arabian horses is not a single-gene disorder.
- Author
-
Ciosek J, Kimes A, Vinardell T, Miller DC, Antczak DF, and Brooks S
- Subjects
- Animals, Horses genetics, Genome-Wide Association Study, Epilepsy genetics, Epilepsy veterinary, Horse Diseases genetics
- Abstract
Valued for their temperament, beauty, athletic ability, and exhibition in the show ring, Arabian horses are an important component of the horse industry. Juvenile idiopathic epilepsy (JIE), a seizure disorder, is most often reported in Arabian foals from birth to 6 months of age. Affected foals exhibit tonic-clonic seizures lasting as long as 5 min and risking secondary complications like temporary blindness and disorientation. Some foals outgrow this condition, while others die or suffer lifelong complications if not treated. Previous work suggested a strong genetic component to JIE and proposed JIE to be a single-gene trait. In this work, we conducted a genome wide association study (GWAS) in 60 cases of JIE and 120 genetically matched controls, identifying loci suggesting JIE is not caused by a single locus. Coat color (chestnut, gray) phenotypes were used as positive control traits to assess the efficacy of GWAS in this population. Future work will attempt to future define candidate regions and explore a polygenic mode of inheritance., (© The Author(s) 2023. Published by Oxford University Press on behalf of The American Genetic Association. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
24. Outcome comparison of different approaches to aortic root aneurysm.
- Author
-
Gocoł R, Bis J, Malinowski M, Morkisz Ł, Jodłowski M, Darocha T, Ciosek J, Wojakowski W, and Deja MA
- Subjects
- Aortic Valve surgery, Humans, Reoperation, Retrospective Studies, Time Factors, Treatment Outcome, Aortic Aneurysm, Thoracic surgery, Aortic Valve Insufficiency surgery, Heart Valve Prosthesis Implantation methods
- Abstract
Background: The treatment of aortic root aneurysm remains challenging for both cardiac surgeons and cardiologists., Aims: This study aimed to assess and compare the long-term outcomes of different approaches to aortic root replacement (ARR)., Methods: All elective patients operated for aortic root aneurysm with or without aortic regurgitation at our institution over a 10-year period were included. We excluded patients with any degree of aortic stenosis and with active endocarditis. We assessed mortality, freedom from reoperation, freedom from aortic valve regurgitation, and the rate of hemorrhagic and thromboembolic complications., Results: Two hundred and four patients underwent elective aortic root replacement: 107 (53%) valve-sparing aortic root replacement (VSARR), 35 (17%) mechanical Bentall procedure (MB), and 62 (30%) Bio-Bentall procedure (BB). Early mortality for VSARR, BB, and MB group was 2.8%, 4.8%, and 0%, respectively (P = 0.40). Estimated 5-year survival was: 90.2% vs. 78.4% vs. 94.2%, respectively (P = 0.12), 5-year freedom from reoperation: 97.8%, 96.6%, and 96.8%, respectively (P = 0.99). Estimat-ed 5-year freedom from complications was: 94.2%, 83.1% and 57.3% in the VSARR, BB and MB group, respectively (P <0.001). On last follow-up echocardiography, 90.5%, 98.4%, and 97.1% (P = 0.08) of patients were free from aortic regurgitation grade 2 or higher. The median (IQR) aortic valve peak gradient was 9 (6-12) mm Hg, 12 (10-18) mm Hg and 16 (14-22) mm Hg, respectively (P <0.001). Complications were predicted by mechanical Bentall (hazard ratio, 6.70 [2.54-17.63]; P <0.001)., Conclusion: With the same mortality, freedom from reoperation, and a minimal late complication rate in comparison with mechanical Bentall and Bio-Bentall, VSARR might be the preferred approach to aortic root aneurysm.
- Published
- 2022
- Full Text
- View/download PDF
25. Rupture of the membranous septum and aortic root perforation after transcatheter aortic valve implantation successfully treated by surgery.
- Author
-
Hudziak D, Gocoł R, Smołka G, Parma R, Lelek M, Wańha W, Ochała A, Ciosek J, Mizia-Szubryt M, Żak A, Morkisz Ł, Darocha T, Machej L, Deja MA, and Wojakowski W
- Subjects
- Aortic Valve diagnostic imaging, Aortic Valve surgery, Humans, Treatment Outcome, Aortic Valve Stenosis surgery, Heart Valve Prosthesis, Transcatheter Aortic Valve Replacement adverse effects
- Published
- 2022
- Full Text
- View/download PDF
26. Giant pseudocyst of the retroperitoneal space mimicking a lesion arising from the left adrenal gland.
- Author
-
Olakowski M and Ciosek J
- Subjects
- Adrenal Glands diagnostic imaging, Humans, Retroperitoneal Space diagnostic imaging, Adrenal Gland Diseases diagnostic imaging, Adrenal Gland Diseases pathology, Cysts diagnostic imaging
- Abstract
Not required for Clinical Vignette.
- Published
- 2022
- Full Text
- View/download PDF
27. Comparison of bicuspid and tricuspid aortic valve repair.
- Author
-
Gocoł R, Bis J, Malinowski M, Ciosek J, Hudziak D, Morkisz Ł, Jasiński M, and Deja MA
- Subjects
- Aorta, Humans, Retrospective Studies, Treatment Outcome, Aortic Valve, Aortic Valve Insufficiency
- Abstract
Objectives: The aim of this study was to compare the outcomes of tricuspid aortic valve (TAV) and bicuspid aortic valve (BAV) repair., Methods: We assessed mortality, freedom from reoperation and the rate of aortic valve regurgitation recurrence. Mortality in both groups was compared with expected survival, and risk factors for reoperation were identified., Results: From January 2010 to April 2020, a total of 368 elective aortic valve repair procedures were performed, including 223 (60.6%) in patients with TAV. The perioperative mortality was 0.7% in the BAV group and 3.6% in the TAV group (P = 0.079). Estimated survival at 5 years in the BAV versus TAV group was 97 ± 3% vs 80 ± 6%, respectively (P < 0.001). Freedom from reoperation at 5 years in the TAV versus BAV group was 96 ± 3% vs 93 ± 4%, respectively (P = 0.28). Grade 2 or more aortic valve regurgitation was noted in 9.9% of BAV patients and 11% of TAV patients (P = 0.66). Reoperation was predicted by cusp perforation [hazard ratio 15.86 (4.44-56.61); P < 0.001], the use of pericardial patch [hazard ratio 8.58 (1.96-37.53); P = 0.004] and aortic valve annulus diameter >27.5 mm [hazard ratio 3.07 (0.99-9.58); P = 0.053]., Conclusions: BAV repair is as durable as TAV repair. BAV is not a predictor of a higher rate of reoperations. BAV repair yields survival comparable to expected. Cusp perforation, aortic valve annulus diameter >27.5 mm and the use of pericardial patch adversely impact long-term outcome of aortic valve repair., (© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.)
- Published
- 2021
- Full Text
- View/download PDF
28. New Indomalayan Nebularmis species (Heterotardigrada: Echiniscidae) provoke a discussion on its intrageneric diversity.
- Author
-
Gąsiorek P, Vončina K, Ciosek J, Veloso M, Fontoura P, and Michalczyk Ł
- Abstract
Recent years have brought undeniable progress in tardigrade taxonomy, and speciose complexes were detected in a number of phylogenetic lineages. The family Echiniscidae is one such lineage; it is one of the most diverse groups of limno-terrestrial tardigrades and can be characterized as having achieved great evolutionary success. In this contribution, using populations representing several species that originated from the Indomalayan region, we reconstructed phylogenetic affinities within Nebularmis, a recently erected genus within the Echiniscus lineage. Nebularmis auratus sp. nov. and Nebularmis burmensis sp. nov. are described from the Eastern Yoma Mountains and the Shan Hills (Myanmar), Nebularmis bhutanensis sp. nov. is described from the Eastern Himalayas (Bhutan), and Nebularmis indicus sp. nov. is described from the foothills of the Western Ghats (Goa, India). Moreover, males are reported in populations of the last two species. All known members of the genus can be phenotypically differentiated based on minute details of their dorsal sculpture and claws. Moreover, a very wide tropical distribution is demonstrated for Nebularmis cirinoi, recorded for the first time from islands of the Malay Archipelago. Furthemore, novel morphological, genetic, and geographic data allowed for the clarification of the generic diagnosis. Currently available data favor a scenario under which Nebularmis evolved in Southeast Asia and later dispersed to other regions of the globe.
- Published
- 2021
- Full Text
- View/download PDF
29. Long-Term Clinical Outcomes and Carotid Ultrasound Follow-Up of Transcarotid TAVI. Prospective Single-Center Registry.
- Author
-
Hudziak D, Hajder A, Gocol R, Malinowski M, Kazmierski M, Morkisz L, Ciosek J, Wanha W, Jarosinski G, Parma R, Darocha T, and Wojakowski W
- Abstract
This study aimed to prospectively evaluate the safety and long-term clinical outcomes of cerebral-oximetry-guided transcarotid transcatheter aortic valve implantation (TC-TAVI) with systematic follow-up with carotid ultrasound. Thirty-three TCTAVI procedures were performed in our center from 2017 to 2019. Our analysis includes in-hospital outcomes and long-term follow-up data on mortality, echocardiographic parameters, carotid Doppler ultrasound, and VARC-2 defined clinical events. Intraoperatively, one patient died, and one had a transient ischemic attack (TIA). The following events occurred in-hospital postoperatively: myocardial infarction (3.0%), cardiac tamponade (3.0%), new-onset atrial fibrillation (6.3%), need for temporary pacing (27.3%) and need for pacemaker implantation (15%). The mean follow-up was 19.5 ± 9.52 months. In the long-term follow-up, the two-year survival rate was 83% ± 14. The echocardiographic parameters did not differ significantly from the postprocedural values, and the ultrasound did not show any cases of significant vessel narrowing. The mean peak systolic velocity (PSV) was 71.6 cm/s in the left common carotid artery and 70.6 cm/s in the right common carotid artery. In conclusion, cerebral oximetry-guided TC access is safe, has a favorable long-term outcome, and does not increase the risk of plaque formation in the carotid artery. In a carefully selected group of patients, it might be considered as a first-choice alternative to TF access.
- Published
- 2021
- Full Text
- View/download PDF
30. Short-term safety and efficacy of transcarotid transcatheter aortic valve implantation with balloon-expandable vs. self-expandable valves.
- Author
-
Hudziak D, Wańha W, Gocoł R, Parma R, Ochała A, Smolka G, Ciosek J, Darocha T, Deja MA, and Wojakowski W
- Abstract
Introduction: Transfemoral access (TF) is the preferred access for transcatheter aortic valve implantation (TAVI). Transcarotid TAVI (TC-TAVI) is an alternative for patients in whom TF-TAVI is impossible. Two types of valves - balloon-expandable (BE) and self-expandable (SE) - can be used in TC-TAVI procedures., Aim: Comparison of the short-term results of patients treated with TC-TAVI using BE and SE valves., Material and Methods: The retrospective registry included 39 patients in whom the TC-TAVI procedure was performed between 2017 and 2020 (BE-TAVI; n = 10, SE-TAVI; n = 29). Preoperative characteristics, operative and postoperative results, and 30-days mortality were compared., Results: Patients from the BE-TAVI group had higher surgical risk (EuroSCORE) (10.8% (6.2-14.0) vs. 5.5% (4.3-8.7); p = 0.027). The incidence of chronic obstructive pulmonary disease (COPD) was higher in the SE-TAVI group (34.5% vs. 0%; p = 0.040). In terms of other comorbidities, demographics, preprocedural laboratory results, transthoracic echocardiography (TTE), and multislice computed tomography (MSCT), the two groups were comparable. In both groups, we observed 100% procedural success. The median valve size was larger in the SE-TAVI group (29.0 (26.0-29.0) vs. 26.0 (23.0-26.0); p < 0.001). The hospitalization time was shorter in the BE-TAVI group vs. SE-TAVI (5.8 ±0.6 vs. 6.4 ±0.9; p = 0.043). We did not observe statistically significant differences between BE-TAVI and SE-TAVI in periprocedural and 30-day mortality, or the number of strokes/TIA. Also TTE parameters and NYHA class showed similar improvement at 30 days in both groups., Conclusions: TC-TAVI using balloon-expandable and self-expandable valves showed similar safety and efficacy in 30 days follow-up., Competing Interests: The authors declare no conflict of interest., (Copyright: © 2021 Termedia Sp. z o. o.)
- Published
- 2021
- Full Text
- View/download PDF
31. Comparison of the short-term safety and efficacy of transcarotid and transfemoral access routes for transcatheter aortic valve implantation.
- Author
-
Hudziak D, Wojakowski W, Malinowski M, Gocoł R, Żak A, Morkisz Ł, Ochała A, Parma R, Smolka G, Ciosek J, Nowak A, Lelek M, and Deja MA
- Subjects
- Aortic Valve surgery, Fluoroscopy, Humans, Retrospective Studies, Treatment Outcome, Aortic Valve Stenosis surgery, Transcatheter Aortic Valve Replacement adverse effects
- Abstract
Background: Transfemoral access is the preferred approach for transcatheter aortic valve implantation (TAVI), as it is characterized by the lowest complication rate. In the majority of patients ineligible for transfemoral access, the transcarotid approach can be used., Aims: This study aimed to compare short‑term outcomes in 2 groups of patients treated with transcarotid or transfemoral TAVI., Methods: A retrospective comparison included 265 patients in whom the TAVI procedure was performed between 2017 and 2019 (transcarotid TAVI, n = 33; transfemoral TAVI, n = 232). Preoperative characteristics, procedural and postprocedural outcomes, as well as 30‑day mortality were assessed., Results: Compared with the transfemoral TAVI group,patients undergoing transcarotid TAVI presented with a higher New York Heart Association (NYHA) functional class (median [interquartile range (IQR)], 3 [3-3] vs 2 [2-3]; P <0.001), a higher surgical risk (median [IQR] EuroSCORE II, 6 [4.8-10.7] vs 4.8 [2.8-7.9]; P = 0.003), and a higher incidence of peripheral artery disease (36.4% vs 18.1%; P = 0.035). The median (IQR) procedure duration in the transcarotid TAVI group was shorter than in patients undergoing transfemoral TAVI (65 [60-80] min vs 90 [80-110] min; P <0.001, respectively). In both study groups, we noted a high percentage of procedural success (transcarotid vs transfemoral TAVI, 96.9% vs 97.2%; P = 0.66). We found no significant differences between transcarotid TAVI and transfemoral TAVI in terms of periprocedural and 30‑day mortality as well as the number of strokes. Regardless of the access route chosen, echocardiographic parameters and the NYHA class similarly improved compared with preprocedural data., Conclusions: Despite posing a higher baseline risk and presenting a greater anatomic complexity, transcarotid access is safe and associated with 30‑day outcomes similar to those observed for transfemoral access. Importantly, procedural time was short and no periprocedural strokes or vascular complications were reported.
- Published
- 2021
- Full Text
- View/download PDF
32. The assessment of serum and diagnostic peritoneal lavage concentration of matrix metalloproteinase-2, matrix metalloproteinase-9, carbohydrate antigen 19-9, and carcinoembryonic antigen in patients with pancreatic cancer and chronic pancreatitis.
- Author
-
Dranka-Bojarowska D, Lewinski A, Lekstan A, Gajda M, Ciosek J, and Mrowiec S
- Subjects
- Adult, Aged, CA-19-9 Antigen blood, Carcinoembryonic Antigen blood, Diagnosis, Differential, Female, Humans, Male, Matrix Metalloproteinase 2 blood, Matrix Metalloproteinase 9 blood, Middle Aged, Pancreatic Neoplasms metabolism, Pancreatitis, Chronic metabolism, CA-19-9 Antigen analysis, Carcinoembryonic Antigen analysis, Matrix Metalloproteinase 2 analysis, Matrix Metalloproteinase 9 analysis, Pancreatic Neoplasms diagnosis, Pancreatitis, Chronic diagnosis, Peritoneal Lavage
- Abstract
Pancreatic cancer and chronic pancreatitis are still significant diagnostic and clinical problems. A tumor marker that would eliminate the imperfection of preoperative serum carbohydrate antigen 19-9 (CA19-9) concentration is still being sought. This study aimed to conduct a comparative analysis of the concentrations in serum and peritoneal cavity of matrix metalloproteinases: metalloproteinase-2 (MMP-2), metalloproteinase-9 (MMP-9), CA19-9, and carcinoembryonic antigen (CEA) in patients with pancreatic cancer (PC), chronic pancreatitis (CP) and a control group (CG). The study was performed in a group of 90 patients. Group 1 consisted of 30 patients with PC, group 2 consisted of 30 patients with CP. There was no case of pancreatic cancer in the CP group. Group 3 (CG) consisted of 30 individuals, who were recruited among patients operated for non-inflammatory cholelithiasis. The serum samples and intraperitoneal fluid, when present or samples of peritoneal lavage were taken from patients and the concentration of MMP-2, MMP-9, and CA19-9 were evaluated. The revealed intraperitoneal fluid concentrations of the MMP-2, MMP-9, and CA19-9 were significantly higher in both PC and CP groups in comparison to CG. There were no statistically significant differences between intraperitoneal fluid concentrations of the MMP2, MMP9, and CA19-9 in PC and CP groups. The revealed serum concentration of the MMP-2 and MMP-9 in the PC, CP, and CG were significantly higher compared to the intraperitoneal fluid. There was no significant correlation between serum and intraperitoneal fluid concentration of the MMP-2, MMP-9, and CA19-9 and the presence of cancer cells in the intraperitoneal fluid conventional cytological examination. The elevated preoperative intraperitoneal fluid concentration of MMP-2 and MMP-9 and serum concentration of CA19-9 and CEA showed significant sensitivity and specificity in PC prediction. The preoperative serum concentrations of MMP-2 and MMP-9, serum, and intraperitoneal fluid concentrations of CA19-9 and CEA have been shown to have a statistically significant effect on predicting cancer progression and the presence of distant metastases. Presented findings suggest the usefulness of MMP-2 and MMP-9 as a potential predictor of PC and marker of dissemination but its usefulness in the differential diagnosis between PC and CP is limited, however more studies on a large population are needed to support our result. To our knowledge, this was the first study evaluating not only MMP-2 and MMP-9 concentrations in serum but also the concentration of these metalloproteinases in peritoneal fluid in patients with PC and CP.
- Published
- 2020
- Full Text
- View/download PDF
33. Long-term outcomes of aortic valve repair in over 500 consecutive patients: a single-center experience.
- Author
-
Gocoł R, Malinowski M, Bis J, Hudziak D, Ciosek J, Wojakowski W, Gaszewska-Żurek E, Jasiński M, and Deja MA
- Subjects
- Adult, Aged, Aortic Valve surgery, Female, Humans, Male, Middle Aged, Reoperation, Retrospective Studies, Treatment Outcome, Aortic Dissection surgery, Aortic Valve Insufficiency surgery, Cardiac Surgical Procedures
- Abstract
Background: Over the last years, aortic valve repair has evolved from being a random and irreproducible procedure to a standardized technique yielding durable long‑term results., Aims: The aim of the study was to assess long‑term outcomes of aortic valve repair and aortic valve sparing procedures., Methods: We analyzed the outcomes of all consecutive patients who underwent aortic valve repair and/ or aortic valve sparing root replacement till the end of 2019. We assessed mortality, freedom from reoperation, and freedom from at least moderate aortic valve regurgitation., Results: A total of 504 patients underwent aortic valve repair and/or aortic valve sparing root replacement over 17 years, including 452 (89.7%) elective and 52 (10.3%) emergency surgeries for acute type A aortic dissections. Median (interquartile range) age was 59 (35-66) years, 72.4% were male. Median follow‑up time was 35 months. Estimated 5‑year survival was 83%, and 10‑year survival was 73%. In 452 patients after elective surgery, the estimated actuarial 5‑year and 10‑year survival was 86% and 75%, respectively. In patients after emergency surgery for acute type A aortic dissection, actuarial 5‑year survival was 62%, and 10‑year survival was 62%. Estimated 5- and 10‑year freedom from reoperation was 96% and 87%, respectively. The comparison of both subgroups did not reveal differences (P = 0.42). Freedom from at least moderate aortic valve regurgitation was confirmed in 86.6% of patients., Conclusions: Aortic valve repair is a durable and effective surgical procedure associated with low early and late mortality. Aortic valve reconstruction in patients with acute type A aortic dissection yields good long‑term results.
- Published
- 2020
- Full Text
- View/download PDF
34. Can the fate be cheated? Septic shock in the course of an abdominal multi-organ trauma - a case report.
- Author
-
Wiórek A, Woźniak N, Morawska I, Bartocha D, Ciosek J, Mrowiec S, and Krzych Ł
- Subjects
- Adult, Humans, Male, Abdominal Injuries therapy, Multiple Trauma therapy, Shock, Septic therapy
- Published
- 2020
- Full Text
- View/download PDF
35. Disruption of histamine/H 3 receptor signal reduces collagen deposition in cultures scar myofibroblasts.
- Author
-
Piera L, Olczak S, Kun T, Galdyszynska M, Ciosek J, Szymanski J, and Drobnik J
- Subjects
- Animals, Cells, Cultured, Heart drug effects, Imidazoles pharmacology, Male, Mast Cells drug effects, Mast Cells metabolism, Myocardial Infarction drug therapy, Myocardial Infarction metabolism, Rats, Rats, Wistar, Thiourea analogs & derivatives, Thiourea pharmacology, Cicatrix metabolism, Collagen metabolism, Histamine metabolism, Myofibroblasts metabolism, Receptors, Histamine metabolism
- Abstract
A suitable inflammatory signal influences extracellular matrix accumulation and determines the quality of the myocardial infarction scar. The aim of the present study was to determine the influence of mast cell sonicates or histamine on collagen accumulation in heart myofibroblast culture and on the deposition of collagen in the myocardial infarction scar. The histamine receptor involved in the process was investigated. Myocardial infarction was induced by ligation of the left coronary artery. Myofibroblasts were isolated from the scar of myocardial infarction. The effects of mast cell sonicates, histamine and its receptor antagonists, i.e. ketotifen (H
1 -receptor inhibitor), ranitidine (H2 -receptor inhibitor), ciproxifan (H3 -receptor inhibitor), JNJ7777120 (H4 -receptor inhibitor), imetit (H3 receptor agonist), were investigated. The mast cell sonicates or histamine (10-10 - 10-5 M) augmented collagen content in myofibroblast cultures; however, histamine-induced elevation was reduced by ciproxifan (10- 5M, 10-6 M). Imetit (10-9 - 10-5 M) elevated collagen content in the culture. H3 receptor expression on myofibroblasts was confirmed. Our findings indicate that histamine increases the deposition of collagen in cultures of myofibroblasts isolated from the myocardial infarction scar. This effect is dependent on H3 receptor activation.- Published
- 2019
- Full Text
- View/download PDF
36. Prospective registry on cerebral oximetry-guided transcarotid TAVI in patients with moderate-high risk aortic stenosis.
- Author
-
Hudziak D, Nowak A, Gocoł R, Parma R, Ciosek J, Ochała A, Deja M, and Wojakowski W
- Subjects
- Aged, Aged, 80 and over, Aortic Valve Stenosis surgery, Echocardiography, Female, Humans, Male, Pilot Projects, Registries, Tomography, X-Ray Computed, Aortic Valve Stenosis diagnostic imaging, Carotid Artery, Common, Oximetry methods, Transcatheter Aortic Valve Replacement methods
- Abstract
Background: The aim of the study was to assess safety TAVI procedure through the common carotid artery in high-vascular-risk patients., Methods: The approach was selected by a multidisciplinary (cardiologists and cardiac surgeons) heart team after analyzing preoperative coronary angiography, transthoracic echocardiography and multislice contrast computed tomography of the peripheral arteries. Patients with the following conditions were qualified to the transcarotid access: severe peripheral artery disease (stenotic, heavily calcified), tortuous or small diameter <6 mm iliofemoral arteries, descending and abdominal aortic disease., Results: Ten transcarotid transcatheter aortic valve implantation procedures were performed in our hospital from September 2017 to May 2018. There were no in-hospital deaths or strokes. The procedural success rate defined as the implantation of the valve with no coronary obstruction and less than moderate paravalvular leak was 100%. Parameters of regional cerebral oximetry were symmetrical on the left and right side in all cases and only during rapid ventricular pacing transiently decreased below the value of 50%. Postoperative cerebrovascular complications and myocardial infarctions were not observed. Statistically significant reduction of the echocardiographic parameters (PGmax and PGmean, Vmax) were observed. Mild paravalvular leaks occurred in 4 patients. Additionally, the heart failure symptoms diminished after the procedure from a median class III to class II. In the 3-month follow-up, mortality is 10% (unknown cause of death of one patient). The mean NYHA class of the other patients is II. Echocardiographic parameters are comparable to postoperative day 4., Conclusions: The pilot registry showed the safety of transcarotid approach in patients with the anatomy precluding the transfemoral approach.
- Published
- 2019
- Full Text
- View/download PDF
37. The giant aortic root aneurysm related to bicuspid aortic valve treated with valve-sparing operation.
- Author
-
Gocoł R, Żak A, Ciosek J, and Deja MA
- Subjects
- Adult, Aortic Aneurysm diagnostic imaging, Aortic Aneurysm etiology, Aortic Valve diagnostic imaging, Aortic Valve surgery, Bicuspid Aortic Valve Disease, Blood Vessel Prosthesis, Heart Valve Diseases complications, Heart Valve Diseases diagnostic imaging, Humans, Prosthesis Design, Treatment Outcome, Aortic Aneurysm surgery, Aortic Valve abnormalities, Blood Vessel Prosthesis Implantation instrumentation, Cardiac Surgical Procedures, Heart Valve Diseases surgery
- Published
- 2019
- Full Text
- View/download PDF
38. Effects of trans-endocardial delivery of bone marrow-derived CD133+ cells on angina and quality of life in patients with refractory angina: A sub-analysis of the REGENT-VSEL trial.
- Author
-
Jadczyk T, Ciosek J, Michalewska-Wludarczyk A, Szot W, Parma Z, Ochala B, Markiewicz M, Rychlik W, Kostkiewicz M, Gruszczynska K, Blach A, Dzierzak-Mietla M, Rzeszutko L, Partyka L, Zasada W, Smolka G, Pawlowski T, Jedrzejek M, Starek Z, Plens K, Ochala A, Tendera M, and Wojakowski W
- Subjects
- Angina Pectoris physiopathology, Bone Marrow Cells cytology, Double-Blind Method, Endocardium, Female, Humans, Injections, Male, Middle Aged, Surveys and Questionnaires, Transplantation, Autologous, Treatment Outcome, AC133 Antigen immunology, Angina Pectoris therapy, Bone Marrow Cells immunology, Bone Marrow Transplantation methods, Quality of Life, Ventricular Function, Left physiology
- Abstract
Background: The REGENT-VSEL trial demonstrated a neutral effect of transendocardial injection of autologous bone marrow (BM)-derived CD133+ in regard to myocardial ischemia. The current sub-analysis of the REGENT VSEL trial aims to assess the effect stem cell therapy has on quality of life (QoL) in patients with refractory angina., Methods: Thirty-one patients (63.0 ± 6.4 years, 70% male) with recurrent CCS II-IV angina, despite optimal medical therapy, enrolled in the REGENT-VSEL single center, randomized, double-blinded, and placebo-controlled trial. Of the 31 patients, 16 individuals were randomly assigned to the active stem cell group and 15 individuals were randomly assigned to the placebo group on a 1:1 basis. The inducibility of ischemia, (≥ one myocardial segment) was confirmed for each patient using Tc-99m SPECT. QoL was measured using the Seattle Angina Questionnaire. Each patient completed the questionnaire prior to treatment and at the time of their outpatient follow-up visits at 1, 4, 6, and 12 months after cell/placebo treatment., Results: The main finding of the REGENT-VSEL trial sub-analysis was that transendocardial injection of autologous BM-derived CD133+ stem cells in patients with chronic refractory angina did not show significant improvement in QoL in comparison to the control group. Moreover, there was no significant difference between cell therapy and placebo in a number of patients showing improvement of at least 1 Canadian Cardiovascular Society class during the follow-up period., Conclusions: Intra-myocardial delivery of autologous CD133+ stem cells is safe and feasible but does not show a significant improvement in the QoL or angina pectoris symptoms in patients with chronic myocardial ischemia.
- Published
- 2018
- Full Text
- View/download PDF
39. Effects of electrospun scaffolds of di- O -butyrylchitin and poly-(ε-caprolactone) on wound healing.
- Author
-
Drobnik J, Krucinska I, Komisarczyk A, Sporny S, Szczepanowska A, and Ciosek J
- Subjects
- Animals, Caproates adverse effects, Chitin adverse effects, Chitin therapeutic use, Lactones adverse effects, Male, Rats, Rats, Wistar, Caproates therapeutic use, Chitin analogs & derivatives, Lactones therapeutic use, Tissue Scaffolds, Wound Healing, Wounds and Injuries therapy
- Abstract
Background: We sought to determine the usefulness of electrospun dibutyrylchitin (DBC) or poly-(ε-caprolactone [PCL]), in wound treatment. We investigated the mechanisms of action of these polymers on wound healing., Methods: We synthesized DBC, a newly identified ester derivative of chitin, using a patented method comprising the substitution of butyryl groups at positions C-3 and C-6 in chitin molecules. We confirmed the double substitution by the butyric groups using infrared spectrometry. The fibrous scaffolds were obtained using the electrospinning method. A polypropylene net was implanted subcutaneously in the rat and served as a wound model., Results: Both DBC and PCL increased granulation tissue weight in the wound. In contrast to PCL, DBC did not abolish glycosaminoglycan changes in wounds. The tested samples did not impair total collagen synthesis or induce excessive fibrosis. In both PCL- and DBC-treated wounds, we observed a lower level of soluble collagen (compared with controls). The results show better hydration of the wounds in both the DBC and PCL groups. No induction of large edema formation by the tested materials was observed. These polymers induced almost identical macrophage-mediated reactions to foreign-body implantation. The implants increased the blood vessel number in a wound., Conclusion: Both PCL and DBC could be used as scaffolds or dressings for wound treatment. The materials were safe and well tolerated by animals. As DBC did not disturb glycosaminoglycan accumulation in wounds and absorbed twice as much liquid as PCL, it can be considered superior.
- Published
- 2017
- Full Text
- View/download PDF
40. The role of histamine in the regulation of the viability, proliferation and transforming growth factor β1 secretion of rat wound fibroblasts.
- Author
-
Wolak M, Bojanowska E, Staszewska T, Ciosek J, Juszczak M, and Drobnik J
- Subjects
- Animals, Cells, Cultured, Fibroblasts metabolism, Histamine Agonists pharmacology, Histamine H1 Antagonists pharmacology, Male, Rats, Rats, Wistar, Receptors, Histamine H1 metabolism, Cell Proliferation drug effects, Cell Survival drug effects, Fibroblasts drug effects, Histamine pharmacology, Transforming Growth Factor beta1 metabolism, Wound Healing drug effects
- Abstract
Background: Inflammation mediators play a regulatory role in repair processes. The study will examine the influence of histamine on wound fibroblast metabolic activity, viability, proliferation, and TGFβ1 secretion. The study also will identify the histamine receptor involved in regulation of the tested repair processes., Methods: Fibroblasts were obtained from the granulation tissue of wounds or intact dermis of rats. The MTT and BrdU assays were used to examine the effect of histamine (10
-8 M-10-4 M) on the viability and metabolic activity of fibroblasts, and on their proliferative capacity. The influence of histamine receptor antagonists (i.e., ketotifen, ranitidine, ciproxifan and JNJ7777120) and agonists (2-pyridylethlamine dihydrochloride, amthamine dihydrobromide) was also investigated. The TGFβ1 and histamine receptors H1 were evaluated by enzyme-linked immunosorbent assay., Results: Histamine significantly increased granulation tissue fibroblast viability and metabolic activity at 10-8 and 10-6 M but did not change their proliferative activity. Only the blockade of the H1 receptor removed this effect of histamine. H1 receptor agonist (2-pyridylethlamine dihydrochloride) increased cell viability, thereby mimicking histamine action. Both Histamine (10-4 M) and 2-pyridylethlamine dihydrochloride increased TGFβ1 concentration in cell culture medium. However, ketotifen blocked histamine-induced augmentation of TGFβ1. H1 receptor expression on wound fibroblasts was confirmed., Conclusion: The regulatory influence of histamine on wound fibroblast function (viability/metabolic activity or secretion of TGFβ1) is dependent on H1 receptor stimulation. Contrary to wound fibroblasts, these cells express a very low level of H1 receptors when isolated from intact dermis and histamine is unable to modify their metabolic activity., (Copyright © 2016. Published by Elsevier Urban & Partner Sp. z o.o.)- Published
- 2017
- Full Text
- View/download PDF
41. Effects of Transendocardial Delivery of Bone Marrow-Derived CD133 + Cells on Left Ventricle Perfusion and Function in Patients With Refractory Angina: Final Results of Randomized, Double-Blinded, Placebo-Controlled REGENT-VSEL Trial.
- Author
-
Wojakowski W, Jadczyk T, Michalewska-Włudarczyk A, Parma Z, Markiewicz M, Rychlik W, Kostkiewicz M, Gruszczyńska K, Błach A, Dzier Zak-Mietła M, Wańha W, Ciosek J, Ochała B, Rzeszutko Ł, Cybulski W, Partyka Ł, Zasada W, Włudarczyk W, Dworowy S, Kuczmik W, Smolka G, Pawłowski T, Ochała A, and Tendera M
- Subjects
- Aged, Angina Pectoris epidemiology, Bone Marrow Cells physiology, Canada epidemiology, Double-Blind Method, Endocardium cytology, Female, Follow-Up Studies, Humans, Magnetic Resonance Imaging methods, Male, Middle Aged, Prospective Studies, Tomography, Emission-Computed, Single-Photon methods, Transplantation, Autologous methods, Treatment Outcome, AC133 Antigen administration & dosage, Angina Pectoris diagnostic imaging, Angina Pectoris therapy, Bone Marrow Transplantation methods, Endocardium physiology, Ventricular Function, Left physiology
- Abstract
Rationale: New therapies for refractory angina are needed., Objective: Assessment of transendocardial delivery of bone marrow CD133
+ cells in patients with refractory angina., Methods and Results: Randomized, double-blinded, placebo-controlled trial enrolled 31 patients with recurrent Canadian Cardiovascular Society II-IV angina, despite optimal medical therapy, ≥1 myocardial segment with inducible ischemia in Tc-99m SPECT who underwent bone marrow biopsy and were allocated to cells (n=16) or placebo (n=15). Primary end point was absolute change in myocardial ischemia by SPECT. Secondary end points were left ventricular function and volumes by magnetic resonance imaging and angina severity. After 4 months, there were no significant differences in extent of inducible ischemia between groups (summed difference score mean [±SD]: 2.60 [2.6] versus 3.63 [3.6], P =0.52; total perfusion deficit: 3.60 [3.6] versus 5.01 [4.3], P =0.32; absolute changes of summed difference score: -1.38 [5.2] versus -0.73 [1.9], P =0.65; and total perfusion deficit: -1.33 [3.3] versus -2.19 [6.6], P =0.65). There was a significant reduction of left ventricular volumes (end-systolic volume: -4.3 [11.3] versus 7.4 [11.8], P =0.02; end-diastolic volume: -9.1 [14.9] versus 7.4 [15.8], P =0.02) and no significant change of left ventricular ejection fraction in the cell group. There was no difference in number of patients showing improvement of ≥1 Canadian Cardiovascular Society class after 1 (41.7% versus 58.3%; P =0.68), 4 (50% versus 33.3%; P =0.63), 6 (70% versus 50.0%; P =0.42), and 12 months (55.6% versus 81.8%; P =0.33) and use of nitrates after 12 months., Conclusion: Transendocardial CD133+ cell therapy was safe. Study was underpowered to conclusively validate the efficacy, but it did not show a significant reduction of myocardial ischemia and angina versus placebo., Clinical Trial Registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01660581., (© 2016 American Heart Association, Inc.)- Published
- 2017
- Full Text
- View/download PDF
42. Patients' Opinions about Polish Surgeons and Surgical Treatment.
- Author
-
Olakowski M, Hładoń A, Seweryn M, Ciosek J, and Świątkiewicz W
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Patients, Poland, Practice Guidelines as Topic, Surgeons, Attitude of Health Personnel, Patient Satisfaction, Physician-Patient Relations, Surgical Procedures, Operative
- Abstract
In Polish society Stereotypes about the surgeons are deeply rooted, which could really affect their relationship with the patient and the entire treatment process. The aim of the study was to evaluate the results of an opinion survey on the image of the surgeon and operative treatment., Material and Methods: Between 1 January and 30 October 2012, 1000 patients were examined by use of a original questionnaire containing 25 questions. Results were analyzed statistically by STATISTICA test. Differences between groups were tested using Chi-square test (X2) with Yates modification, adopting the significance level α = 0.05., Results: The study group consisted of 1000 patients, including 56% of women (n = 560) and 44% of men (n = 440). The media image of Polish surgeon was identified as positive by 78% of respondents. A majority of patients (74%) considered that the Polish surgeons had equal level of competence and skills as foreign specialists. The greatest trust of the respondents (n = 537) had surgeons in middle age (40-60 years). For the majority of patients (n = 649) a sex of the surgeon had no significance. Respondents clearly stated that a surgeon performing the operation should not have additional financial rewards. Almost all respondents in medical emergencies without hesitation declared their agreement to surgery (n = 974)., Conclusions: Present knowledge of Polish patients about surgeons and surgical treatment is high. The surgeon has a high social prestige, respect and appreciation, and his image in the opinion of the vast majority of respondents is positive.
- Published
- 2016
- Full Text
- View/download PDF
43. Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference Behavior.
- Author
-
Bojanowska E and Ciosek J
- Subjects
- Animals, Brain physiopathology, Energy Metabolism, Homeostasis drug effects, Humans, Neuropeptides physiology, Satiety Response drug effects, Anti-Obesity Agents therapeutic use, Appetite Regulation drug effects, Brain drug effects, Brain physiology, Food Preferences drug effects, Obesity drug therapy
- Abstract
Excessive intake of food, especially palatable and energy-dense carbohydrates and fats, is largely responsible for the growing incidence of obesity worldwide. Although there are a number of candidate antiobesity drugs, only a few of them have been proven able to inhibit appetite for palatable foods without the concurrent reduction in regular food consumption. In this review, we discuss the interrelationships between homeostatic and hedonic food intake control mechanisms in promoting overeating with palatable foods and assess the potential usefulness of systemically administered pharmaceuticals that impinge on the endogenous cannabinoid, opioid, aminergic, cholinergic, and peptidergic systems in the modification of food preference behavior. Also, certain dietary supplements with the potency to reduce specifically palatable food intake are presented. Based on human and animal studies, we indicate the most promising therapies and agents that influence the effectiveness of appetite-modifying drugs. It should be stressed, however, that most of the data included in our review come from preclinical studies; therefore, further investigations aimed at confirming the effectiveness and safety of the aforementioned medications in the treatment of obese humans are necessary.
- Published
- 2016
- Full Text
- View/download PDF
44. [Galanin-like peptide (GALP): localization, receptors and biological function].
- Author
-
Wodowska J and Ciosek J
- Subjects
- Adult, Female, Humans, Male, Eating physiology, Energy Metabolism physiology, Galanin-Like Peptide metabolism, Homeostasis physiology, Hypothalamus metabolism, Pituitary Gland metabolism, Receptors, Galanin metabolism
- Abstract
Galanin-like peptide (GALP) was isolated from porcine hypothalamus in 1999 on the basis of its ability to activate galanin receptors in vitro. Extensive studies carried out since the discovery of GALP contributed to the significant progress in our knowledge regarding this neuropeptide. GALP is synthesized mainly in the neurons of the hypothalamic arcuate nucleus and in the pituicytes of the posterior pituitary. The effects of GALP are mediated by well-characterized G-protein coupled galanin receptor subtypes. The fact that GALP shares homology only with 13 amino acids of the galanin sequence suggests that it might also interact with its own specific receptor. This relatively small 60-amino acid peptide belongs to a growing list of neuropeptides that play a crucial role in the regulation of food intake, energy balance and the reproductive axis. This peptide appears to be involved in integrating energy balance control and reproduction. The paper presents the current state of knowledge about the biosynthesis, structure, localization of GALP and its receptors, with particular emphasis on its role. This review will attempt to summarize the significant body of in vitro and in vivo studies conducted so far, concerning the effects of GALP.
- Published
- 2015
45. Galanin and galanin-like peptide modulate vasopressin and oxytocin release in vitro: the role of galanin receptors.
- Author
-
Wodowska J and Ciosek J
- Subjects
- Animals, Galanin analogs & derivatives, Galanin pharmacology, Galanin-Like Peptide pharmacology, Hypothalamo-Hypophyseal System drug effects, Male, Rats, Rats, Wistar, Receptors, Galanin antagonists & inhibitors, Substance P analogs & derivatives, Substance P pharmacology, Galanin physiology, Galanin-Like Peptide physiology, Hypothalamo-Hypophyseal System metabolism, Oxytocin metabolism, Receptors, Galanin physiology, Vasopressins metabolism
- Abstract
Galanin (Gal) and galanin-like peptide (GALP) may be involved in the mechanisms of the hypothalamo-neurohypophysial system. The aim of the present in vitro study was to compare the influence of Gal and GALP on vasopressin (AVP) and oxytocin (OT) release from isolated rat neurohypophysis (NH) or hypothalamo-neurohypophysial explants (Hth-NH). The effect of Gal/GALP on AVP/OT secretion was also studied in the presence of galantide, the non-selective galanin receptors antagonist. Gal at concentrations of 10(-10 )M and 10(-8 )M distinctly inhibited basal and K(+)-stimulated AVP release from the NH and Hth-NH explants, whereas Gal exerted a similar action on OT release only during basal incubation. Gal added to the incubation medium in the presence of galantide did not exert any action on the secretion of either neurohormone from NH and Hth-NH explants. GALP (10(-10 )M and 10(-9 )M) induced intensified basal AVP release from the NH and Hth-NH complex as well as the release of potassium-evoked AVP from the Hth-NH. The same effect of GALP has been observed in the presence of galantide. GALP added to basal incubation medium was the reason for stimulated OT release from the NH as well as from the Hth-NH explants. However, under potassium-stimulated conditions, OT release from the NH and Hth-NH complexes has been observed to be distinctly impaired. Galantide did not block this inhibitory effect of GALP on OT secretion. It may be concluded that: (i) Gal as well as GALP modulate AVP and OT release at every level of the hypothalamo-neurohypophysial system; (ii) Gal acts in the rat central nervous system as the inhibitory neuromodulator for AVP and OT release via its galanin receptors; (iii) the stimulatory effect of GALP on AVP and OT release is likely to be mediated via an unidentified specific GALP receptor(s)., (Copyright © 2014 Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
46. Melatonin-induced glycosaminoglycans augmentation in myocardium remote to infarction.
- Author
-
Drobnik J, Tosik D, Piera L, Szczepanowska A, Olczak S, Zielinska A, Liberski PP, and Ciosek J
- Subjects
- Animals, Cells, Cultured, Collagen metabolism, Fibroblasts drug effects, Fibroblasts metabolism, Heart Ventricles cytology, Heart Ventricles metabolism, Male, Myocardial Infarction metabolism, Rats, Rats, Wistar, Receptors, Melatonin antagonists & inhibitors, Tryptamines pharmacology, Glycosaminoglycans metabolism, Melatonin pharmacology, Myocardium metabolism
- Abstract
Elevated levels of collagen as well as transient increases of glycosaminoglycans (GAG) have been shown in the myocardium remote to the infarction. The aim of the study is to observe the effect of melatonin on the accumulation of collagen and GAG in the left ventricle wall, remote to the infarction. A second aim is to determine whether the effect of the pineal indole is mediated by the membrane melatonin receptors of heart fibroblasts. Rats with myocardial infarction induced by ligation of the left coronary artery were treated with melatonin at a dose of 60 μg/100 g b.w. or vehicle (2% ethanol in 0.9% NaCl). The results were compared with an untreated control. In the second part of the study, the fibroblasts from the non-infarcted part of myocardium were isolated and cultured. Melatonin at a range of concentrations from 10(-8) M to 10(-6) M was applied to the fibroblast cultures. In the final part of the study, the influence of luzindole (10(-6) M), the melatonin membrane receptor inhibitor, on melatonin-induced GAG augmentation was investigated. Both collagen and GAG content were measured in the experiment. Melatonin elevated GAG content in the myocardium remote to the infarcted heart. Collagen level was not changed by pineal indoleamine. Fibroblasts isolated from the myocardium varied in shape from fusiform to spindle-shaped. Moreover, the pineal hormone (10(-7)M and 10(-6)M) increased GAG accumulation in the fibroblast culture. Luzindole inhibited melatonin-induced elevation of GAG content at 10(-6)M. Melatonin increased GAG content in the myocardium remote to infarction. This effect was dependent on the direct influence of the pineal indole on the heart fibroblasts. The melatonin-induced GAG elevation is blocked by luzindole, the melatonin membrane receptors inhibitor, indicating a direct effect of this indole.
- Published
- 2013
47. Galanin modulates oxytocin release from rat hypothalamo-neurohypophysial explant in vitro - the role of acute or prolonged osmotic stimulus.
- Author
-
Ciosek J and Drobnik J
- Subjects
- Animals, Hypothalamus drug effects, Male, Neurons drug effects, Osmosis, Pituitary Gland, Posterior drug effects, Rats, Rats, Wistar, Galanin pharmacology, Hypothalamo-Hypophyseal System drug effects, Neurotransmitter Agents pharmacology, Oxytocin pharmacology
- Abstract
Introduction: Galanin (Gal) may be involved as the neuromodulator of different processes in the central nervous system in the regulation of neurohypophysial function. The aim of the present study was to examine the influence of Gal on oxytocin (OT) release in vitro: an acute or prolonged osmotic stimulus was used as the stimulatory agent., Material and Methods: Experiments were carried out on three-month old male rats which acted as donors of isolated rat hypothalamus (Hth), neurohypophysis (NH) or hypothalamo-neurohypophysial explants (Hth-NH). The effect of Gal on OT secretion was studied under conditions of non-osmotic (i.e. K(+)-evoked) (series 1), direct osmotic (i.e. Na(+)-evoked) (series 2) or indirect osmotic stimulation (series 3; neural tissues were obtained from animals drinking 2% NaCl). OT content was determined by radioimmunoassay., Results: Galanin added into incubative media caused the inhibition of basal OT release from NH and Hth-NH explants prepared from euhydrated rats but stimulated basal and K(+)-stimulated OT release from the Hth tissue. Gal did not exert any influence on Na(+)-evoked OT secretion. We observed increased basal OT secretion from NH and K(+)-evoked respective OT release from Hth and Hth-NH explants taken from osmotically challenged rats under the influence of Gal., Conclusions: Present experiments in vitro show that: 1. Galanin plays the role of an inhibitory neuromodulator of OT release from the neurohypophysis; its effect is opposite at the hypothalamic level. 2. Galanin acts as the stimulatory neuromodulator of OT release in response to prolonged osmotic stimulus; an acute osmotic stimulus blocks OT-ergic neurons susceptible to Gal.
- Published
- 2013
48. Melatonin-induced augmentation of collagen deposition in cultures of fibroblasts and myofibroblasts is blocked by luzindole--a melatonin membrane receptors inhibitor.
- Author
-
Drobnik J, Owczarek K, Piera L, Tosik D, Olczak S, Ciosek J, and Hrabec E
- Subjects
- Animals, Cells, Cultured, Cicatrix drug therapy, Cicatrix metabolism, Fibroblasts drug effects, Fibroblasts metabolism, Heart drug effects, Male, Myocardial Infarction drug therapy, Myocardial Infarction metabolism, Myofibroblasts metabolism, Rats, Rats, Wistar, Receptors, Melatonin metabolism, Tryptamines pharmacology, Collagen metabolism, Melatonin pharmacology, Myofibroblasts drug effects, Receptors, Melatonin antagonists & inhibitors, Wound Healing drug effects
- Abstract
Background: Melatonin has been proven to have a regulatory influence on collagen accumulation in different types of wound. It was found to inhibit collagen accumulation in the superficial wound model but increase it in the myocardial infarction scar. The aim of the study is to determine the mechanism of melatonin action in the two wound types in rats., Methods: Cells were isolated from both the superficial wound (subcutaneously inserted polypropylene net) and myocardial infarction scar (induced by ligation of the left coronary artery) and were identified by electron microscopy., Results: Long-shaped cells forming whirl-like structures in culture (mainly identified as fibroblasts) were isolated from the superficial wound model, while myofibroblasts growing in a formless manner were acquired from the infarcted heart scar. Melatonin (10(-7) M) increased collagen accumulation in both fibroblast and myofibroblast cultures. Luzindole (10(-6) M), the blocker of both MT1 and MT2 melatonin membrane receptors, inhibited the effect of melatonin on the two types of cells., Conclusion: Regardless of various healing potentials demonstrated by the tested cells (different cell composition, growth and organization), their response to melatonin was similar. Moreover, in the two investigated cultures, augmentation of the collagen content by melatonin was reversed by luzindole, which indicates the possibility of melatonin membrane receptor involvement in that process. The present results suggest that the increased melatonin-stimulated deposition of collagen observed in the infarcted heart of rats could be dependent on activation of the melatonin membrane receptors on scar myofibroblasts.
- Published
- 2013
- Full Text
- View/download PDF
49. Function of the hypothalamo-neurohypophysial system in rats with myocardial infarction is modified by melatonin.
- Author
-
Ciosek J and Drobnik J
- Subjects
- Animals, Arginine Vasopressin blood, Disease Models, Animal, Feedback, Physiological, Hypothalamo-Hypophyseal System metabolism, Hypothalamo-Hypophyseal System physiopathology, Male, Melatonin administration & dosage, Myocardial Infarction blood, Myocardial Infarction physiopathology, Oxytocin blood, Pineal Gland metabolism, Pineal Gland surgery, Radioimmunoassay, Rats, Rats, Wistar, Hypothalamo-Hypophyseal System drug effects, Melatonin pharmacology, Myocardial Infarction drug therapy
- Abstract
Background: Pineal and melatonin interactions with the hypothalamo-neurohypophysial system are well documented. In addition, vasopressin and oxytocin secretion are known to be part of the neuroendocrine response to chronic heart failure evoked by myocardial infarction. The present study was undertaken to evaluate the possible regulatory role of melatonin in the vasopressin and oxytocin release in rats with myocardial infarction., Methods: The vasopressin and oxytocin content of the hypothalamus and neurohypophysis, as well as their plasma levels, were radioimmunoassayed in sham-operated or pinealectomized rats with left coronary artery ligation (CAL)-evoked myocardial infarction as well as under melatonin treatment., Results: Infarcted rats demonstrated increased vasopressin and oxytocin plasma levels, but melatonin restricted the release of both neurohormones in these rats. Experimental myocardial infarction in pinealectomized rats caused a distinct inhibition of vasopressin release but intensified oxytocin secretion. In pinealectomized rats substituted with melatonin, pineal indole amine was seen to inhibit oxytocin release and stimulate vasopressin secretion., Conclusions: (i) CAL-induced myocardial infarction is the reason for increased hypothalamo-neurohypophysial system activity in rats; melatonin plays the role of inhibitory neuromodulator of vasopressin and oxytocin release in this state. (ii) Myocardial infarction evoked in pinealectomized rats is characterized by the inversion of the neurohumoral response pattern in respect of inhibited vasopressin release. (iii) Melatonin stimulates vasopressin (but decreases oxytocin) release in pinealectomized rats with myocardial infarction.
- Published
- 2012
- Full Text
- View/download PDF
50. Galanin and vasopressin response to hyperosmotic stimulation: in vitro study.
- Author
-
Ciosek J and Galecka K
- Subjects
- Animals, Hypothalamo-Hypophyseal System drug effects, Hypothalamo-Hypophyseal System metabolism, Hypothalamus drug effects, Male, Neuropeptides pharmacology, Osmolar Concentration, Paraventricular Hypothalamic Nucleus drug effects, Paraventricular Hypothalamic Nucleus metabolism, Pituitary Gland, Posterior drug effects, Rats, Rats, Wistar, Sodium Chloride pharmacology, Supraoptic Nucleus drug effects, Vasopressins blood, Galanin pharmacology, Hypothalamus metabolism, Pituitary Gland, Posterior metabolism, Vasopressins metabolism
- Abstract
Galanin (Gal)--a neuropeptide present in the nervous system and peripheral tissues--may be involved in the regulation of hypothalamo-neurohypophysial system function. It was shown that centrally injected galanin inhibits osmotically stimulated vasopressin (VP) secretion into the blood and reduces VP mRNA level in the supraoptic (SON) and paraventricular (PVN) hypothalamic nuclei. The aim of the present study in vitro was to investigate the influence of Gal on vasopressin release from isolated rat hypothalamus (Hth), neurohypophysis (NH) or hypothalamo-neurohypophysial explants (Hth-NH). The effect of Gal on VP secretion was studied under conditions of direct osmotic (i.e., Na⁺-evoked) (series 1) as well as nonosmotic (i.e., K⁺-evoked) (series 2) stimulation. In series 3, vasopressin response to Gal was studied using the neural tissues obtained from animals drinking 2 percent NaCl solution for eight days (indirect osmotic stimulation). Gal in a concentration of 10⁻¹⁰ M and 10⁻⁸ M inhibited basal VP release from Hth, NH and Hth-NH explants isolated from euhydrated rats as well as from Hth-NH complex of osmotically challenged animals. When the neural tissues obtained from previously salt-loaded rats were incubated in K⁺-enriched medium the inhibitory effect of Gal was completely blocked. It may be concluded that the effect of Gal is depending on the current functional status of the hypothalamo-neurohypophysial system.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.